AU5060499A - Hydrodynamically balanced oral drug delivery system - Google Patents

Hydrodynamically balanced oral drug delivery system

Info

Publication number
AU5060499A
AU5060499A AU50604/99A AU5060499A AU5060499A AU 5060499 A AU5060499 A AU 5060499A AU 50604/99 A AU50604/99 A AU 50604/99A AU 5060499 A AU5060499 A AU 5060499A AU 5060499 A AU5060499 A AU 5060499A
Authority
AU
Australia
Prior art keywords
delivery system
drug delivery
oral drug
hydrodynamically balanced
balanced oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50604/99A
Other languages
English (en)
Inventor
John N. Staniforth
Naresh Talwar
Michael J. Tobyn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU5060499A publication Critical patent/AU5060499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU50604/99A 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system Abandoned AU5060499A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1999/001386 WO2001010405A1 (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system

Publications (1)

Publication Number Publication Date
AU5060499A true AU5060499A (en) 2001-03-05

Family

ID=11004886

Family Applications (2)

Application Number Title Priority Date Filing Date
AU50604/99A Abandoned AU5060499A (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system
AU63099/00A Ceased AU774957B2 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU63099/00A Ceased AU774957B2 (en) 1999-08-04 2000-08-01 Hydrodynamically balancing oral drug delivery system

Country Status (21)

Country Link
EP (1) EP1206249A4 (de)
JP (1) JP2003506400A (de)
CN (1) CN1376059A (de)
AP (1) AP2002002410A0 (de)
AU (2) AU5060499A (de)
BR (1) BR0012981A (de)
CA (1) CA2378468A1 (de)
CZ (1) CZ2002415A3 (de)
EA (1) EA200200126A1 (de)
HK (1) HK1047226A1 (de)
HR (1) HRP20020108A2 (de)
HU (1) HUP0202497A3 (de)
IL (1) IL147966A0 (de)
MX (1) MXPA02001272A (de)
NZ (1) NZ516959A (de)
OA (1) OA12003A (de)
PL (1) PL353321A1 (de)
SK (1) SK1832002A3 (de)
TR (1) TR200200467T2 (de)
WO (2) WO2001010405A1 (de)
ZA (1) ZA200200926B (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457458B1 (ko) * 2001-04-02 2004-11-17 삼아약품 주식회사 속용정 및 그의 제조방법
ATE477795T1 (de) 2001-07-04 2010-09-15 Sun Pharma Advanced Res Co Ltd Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
WO2003037296A2 (en) * 2001-10-29 2003-05-08 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
JP2007503427A (ja) * 2003-08-27 2007-02-22 ベクタ・リミテッド 胃酸分泌の抑制を必要とする病状を治療するための組成物
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
CA2572864C (en) 2004-08-13 2014-02-11 Boehringer Ingelheim International Gmbh Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
EP1690540A1 (de) * 2005-02-15 2006-08-16 Neuro3D Zusammensetzung enthaltend Ocaperidon
BRPI0620268B8 (pt) 2005-12-22 2021-05-25 Oakwood Laboratories LLC composição eficaz como sistema de fornecimento para liberação controlada, seu uso, seu método de fabricação, e método para proteger um agente biologicamente ativo
EP1886665A1 (de) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastroretentives Freisetzungssystem
ES2350029T3 (es) * 2007-03-02 2011-01-17 Farnam Companies, Inc. Pellets de liberación sostenida que comprenden un material tipo cera.
JP2012500221A (ja) 2008-08-15 2012-01-05 ディポメド,インコーポレイティド Cns障害の処理及び予防のための胃保持性医薬組成物
EP2329810A4 (de) 2008-08-18 2012-09-19 Team Academy Of Pharmaceutical Science Arzneiabgabesystem mit magenretention, herstellungsverfahren und anwendung
AP2011005687A0 (en) 2008-10-08 2011-06-30 Bioplus Life Sciences Pvt Ltd Sustained release drug delivery system.
EP2283824B1 (de) 2009-07-30 2017-04-19 Special Products Line S.p.A. Zusammensetzungen und Formulierungen, die auf quellbaren Matrizen basieren, zur verzögerten Freisetzung von schlecht löslichen Arzneimitteln, wie zum Beispiel Clarithromycin
JP2013103879A (ja) * 2011-11-10 2013-05-30 Nakanihon Capsule Co Ltd ハードカプセル
KR102241487B1 (ko) 2013-02-20 2021-04-16 주식회사 종근당 제어방출 펠릿으로 된 약제학적 조성물
CA2906172C (en) * 2013-03-15 2021-12-21 Aprecia Pharmaceuticals Company Rapidly dispersible dosage form of topiramate
CN103462917A (zh) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 一种用于抗病毒的阿昔洛韦片剂及其制备方法
CN117898368A (zh) * 2016-06-14 2024-04-19 Evah 营养公司 包含饲料添加剂的动物饲料颗粒、其制备和使用方法
CN110996922A (zh) 2017-06-16 2020-04-10 卡希夫生物科学有限责任公司 用于持续药物递送的胃滞留剂型
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
CN107441115A (zh) * 2017-08-22 2017-12-08 安徽省肿瘤医院 一种维拉帕米联合碳酸氢钠在制备原发性肝癌治疗药物中的用途
CN107375287B (zh) * 2017-08-22 2019-11-29 安徽省肿瘤医院 一种硫酸阿托品在制备治疗原发性肝癌药物中的用途
CN107349195A (zh) * 2017-08-22 2017-11-17 安徽省肿瘤医院 一种维拉帕米在制备治疗转移性肝癌药物中的用途
WO2019246145A1 (en) 2018-06-18 2019-12-26 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
EP3970701A1 (de) * 2018-06-27 2022-03-23 Amneal Complex Products Research LLC Selbstregulierende osmotische gastroretentive arzneimittelabgabesysteme
WO2020230089A1 (en) 2019-05-14 2020-11-19 Clexio Biosciences Ltd. Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (de) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
WO1991006281A1 (en) * 1989-10-26 1991-05-16 Nippon Shinyaku Co., Ltd. Gastric preparation
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua

Also Published As

Publication number Publication date
HUP0202497A2 (hu) 2002-11-28
EP1206249A1 (de) 2002-05-22
MXPA02001272A (es) 2002-07-22
CA2378468A1 (en) 2001-02-15
WO2001010405A1 (en) 2001-02-15
HK1047226A1 (zh) 2003-02-14
BR0012981A (pt) 2002-06-18
JP2003506400A (ja) 2003-02-18
PL353321A1 (en) 2003-11-17
TR200200467T2 (tr) 2002-08-21
IL147966A0 (en) 2002-09-12
EA200200126A1 (ru) 2002-10-31
SK1832002A3 (en) 2002-08-06
OA12003A (en) 2006-04-18
AU774957B2 (en) 2004-07-15
NZ516959A (en) 2003-10-31
WO2001010419A1 (en) 2001-02-15
CZ2002415A3 (cs) 2002-08-14
CN1376059A (zh) 2002-10-23
EP1206249A4 (de) 2004-12-22
AU6309900A (en) 2001-03-05
ZA200200926B (en) 2002-11-27
HRP20020108A2 (en) 2003-12-31
HUP0202497A3 (en) 2004-05-28
AP2002002410A0 (en) 2002-03-31

Similar Documents

Publication Publication Date Title
AU5060499A (en) Hydrodynamically balanced oral drug delivery system
AU3287699A (en) Ultrasound-mediated drug delivery
GB9904629D0 (en) Oral drug delivery system
AU2123200A (en) Drug delivery device
AU4981200A (en) Stent delivery system
AU4985600A (en) Drug delivery device
AU6938600A (en) Cervical agent delivery system
AU5259100A (en) Medicament
AU4357800A (en) Intracellular pharmaceutical targeting
AU4661700A (en) Content delivery system
AU4947100A (en) Drug delivery device
AU3520900A (en) Implantable drug delivery system
AU2002343555A1 (en) Eutectic-based self-nanoemulsified drug delivery system
EP1061987A4 (de) Vorrichtung zum verabreichen eines medikamentes
AU7711098A (en) Drug delivery system
AU7201998A (en) Drug delivery system
AU6715600A (en) Pharmaceutical formulations
AU3837999A (en) Drug delivery device
AU4977300A (en) Pharmaceutical formulations
AU1385801A (en) Pharmaceutical formulations
AU6503399A (en) Drug delivery catheter
AU3926000A (en) Methods and compositions for drug delivery
AU2002222138A1 (en) Drug delivery system
AU2002210580A1 (en) Drug delivery system
AU1413700A (en) Information delivery system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase